Chemotherapy-related cognitive dysfunction in breast cancer
- PMID: 14702917
- DOI: 10.1053/j.soncn.2003.09.002
Chemotherapy-related cognitive dysfunction in breast cancer
Abstract
Objectives: To provide an overview of chemotherapy-related cognitive dysfunction in breast cancer survivors, focusing on its pathophysiology, risk factors, assessment, and management.
Data sources: Published biomedical literature.
Conclusion: Chemotherapy-related cognitive dysfunction in patients with breast cancer is multifactorial and possibly related to anemia or a direct effect of chemotherapy on brain function. Clinical observation and subjective reports are useful assessments. Therapies directed at alleviating or preventing cognitive deficits are being investigated.
Implications for nursing practice: Oncology nurses are important in monitoring cognitive function in patients with breast cancer receiving chemotherapy. Nurses who are aware of the risks, assessment, and management of cognitive impairment are better able to discuss these issues with patients and caregivers.
Similar articles
-
Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.Oncol Nurs Forum. 2003 May-Jun;30(3):473-8. doi: 10.1188/03.ONF.473-478. Oncol Nurs Forum. 2003. PMID: 12719746
-
Strategies for success: optimizing oral therapies in breast and colorectal cancer.ONS News. 2006;21(8 Suppl):7-8. ONS News. 2006. PMID: 16925129 Review. No abstract available.
-
Cognitive deficits in Korean women treated with chemotherapy for breast cancer.Cancer Nurs. 2014 May-Jun;37(3):E31-42. doi: 10.1097/NCC.0b013e3182980383. Cancer Nurs. 2014. PMID: 23945143
-
The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.Patient Educ Couns. 2007 Apr;66(1):108-18. doi: 10.1016/j.pec.2006.11.005. Epub 2007 Feb 21. Patient Educ Couns. 2007. PMID: 17320337
-
Management of acute cancer treatment-induced diarrhea.Semin Oncol Nurs. 2003 Nov;19(4 Suppl 3):11-6. doi: 10.1053/j.soncn.2003.09.009. Semin Oncol Nurs. 2003. PMID: 14702928 Review.
Cited by
-
Cognitive dysfunction in cancer patients: an educational needs area improved by a single intervention.J Cancer Educ. 2007 Fall;22(3):197-201. doi: 10.1007/BF03174337. J Cancer Educ. 2007. PMID: 17760529
-
The experience of cognitive change in women with breast cancer following chemotherapy.J Cancer Surviv. 2015 Sep;9(3):375-87. doi: 10.1007/s11764-014-0387-x. Epub 2014 Oct 25. J Cancer Surviv. 2015. PMID: 25343970
-
Doxorubicin treatment has a biphasic effect over time on dopamine release and impulsive behavior in Wistar rats.Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul;398(7):8497-8509. doi: 10.1007/s00210-024-03766-5. Epub 2025 Jan 16. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 39820646
-
Study of Chemotherapy-Induced Cognitive Impairment in Women with Breast Cancer.Int J Environ Res Public Health. 2020 Nov 30;17(23):8896. doi: 10.3390/ijerph17238896. Int J Environ Res Public Health. 2020. PMID: 33265966 Free PMC article. Clinical Trial.
-
Exercise for women receiving adjuvant therapy for breast cancer.Cochrane Database Syst Rev. 2016 Sep 21;9(9):CD005001. doi: 10.1002/14651858.CD005001.pub3. Cochrane Database Syst Rev. 2016. PMID: 27650122 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
